GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
ANDERSON, Niall Andrew,CAMPBELL-CRAWFORD, Matthew Howard James,HANCOCK, Ashley Paul,PRITCHARD, John Martin,REDMOND, Joanna Mary
申请号：
PE2017000380
公开号：
PE20170502A1
申请日:
2015.09.22
申请国别(地区):
PE
年份:
2017
代理人:
摘要：
1. Refers to a formula compound (I), namely 4 - (3-fluoro-3 - (2 - (5,6,7,8-tetrahydro-1,8-neferin-2-ethyl) pyridine-1-one - (3 - (2-methoxy) phenyl), 3 - (3 - (2-methoxy) phenyl) butadiene, which has anti activity to propyl ether recipients, and 6 is used for the treatment of pulmonary fibrosis； He also mentioned an understandable composer of pharmacologySe refiere a un compuesto de formula (I) que es el acido 4-(3-fluoro-3-(2-(5,6,7,8-tetrahidro-1,8-naftiridin-2-il)etil)pirrolidin-1-il)-3-(3-(2-metoxietoxi)fenil)butanoico que tiene actividad antagonista del receptor de integrina aVß6, siendo util para el tratamiento de fibrosis pulmonar； tambien se refiere a una composicion farmaceutica que lo comprende
